HOXB9 was also an enabler of multi-organ metastasis of lung adenocarcinoma by activating the WNT/TCF pathway and was also a metastatic promoter of colon cancer and a potential biomarker of bevacizumab therapy [17]. Here, HOXB9 is linked to malignant colon neoplasm.